PHOENIX group (@PHOENIXPharma) auf X
With a solid annual result in 2021/22, @PHOENIXPharma confirmed its position as a leading healthcare provider in Europe. Revenue grew by 8.9% compared with the previous year to €30.7 bn. With €298.0 m (previous year: €298.7 m) profit before tax was on the level seen in 2020/21twitter.com